KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD defence Anxhela Habibi
"Protease-activated receptors in vascular smooth muscle cells: A bridge between coagulation and vascular remodeling"
17 Oct -
PhD defence Richard Gerardus Johannes Dohmen
"Fat from muscle: Fibro-adipogenic progenitors as a source for cultured fat production"
20 Oct -
PhD defence Navya Premaraj
"Frozen in Time: Visualizing the Glassy State of Life Cryo-EM sample preparation by jet vitrification"
20 Oct